Meeder Asset Management’s Core Laboratories CLB Stock Holding History

Meeder Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-854	Closed	-$12K	–	1009
2022 Q3	$12K	Buy	854 +317	+59%	+$5.34K	﹤0.01%	1257
2022 Q2	$11K	Buy	537 +142	+36%	+$3.77K	﹤0.01%	1332
2022 Q1	$12K	Buy	+395	New	+$11.1K	﹤0.01%	1478
2021 Q4	–	Sell	-304	Closed	-$8K	–	1378
2021 Q3	$8K	Buy	304 +77	+34%	+$2.34K	﹤0.01%	1747
2021 Q2	$9K	Buy	227 +106	+88%	+$3.8K	﹤0.01%	1723
2021 Q1	$3K	Buy	121 +3	+3%	+$102	﹤0.01%	1969
2020 Q4	$3K	Buy	118 +77	+188%	+$1.57K	﹤0.01%	1345
2020 Q3	$1K	Buy	41 +2	+5%	+$42	﹤0.01%	1944
2020 Q2	$1K	Buy	+39	New	+$699	﹤0.01%	1877

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Meeder Asset Management's CLB Position: Q4 2022 in Review

Meeder Asset Management sold out of Core Laboratories (CLB) in Q4 2022, closing a stake of 854 shares — an estimated $12K sold.

Meeder Asset Management first reported a position in CLB in Q2 2020 and held it in 9 quarters. The position peaked at $12K in Q3 2022. 162 funds tracked by Wall St. Rank hold CLB as of Q4 2022.

Meeder Asset Management reported no remaining Core Laboratories position as of Q4 2022 after selling out during the quarter.
Meeder Asset Management sold 854 Core Laboratories shares in Q4 2022, an estimated $12K.
Meeder Asset Management first reported a position in Core Laboratories in Q2 2020 and held it in 9 quarters.
Meeder Asset Management's Core Laboratories position peaked at $12K in Q3 2022.
162 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.